MedPath

Pulpotomy in permanent teeth with symptoms of irreversible pulpitis

Phase 4
Recruiting
Conditions
Pulpitis,
Registration Number
CTRI/2021/07/034842
Lead Sponsor
Jyoti yadav
Brief Summary

1.      To evaluatethe outcome of clinical and radiographic success of partial pulpotomy usingbiodentine in mature permanent molar with clinical symptoms indicative ofirreversible pulpitis.

2.      To evaluatethe outcome of clinical and radiographic success of full pulpotomy usingbiodentine in mature permanent molar with clinical symptoms indicative ofirreversible pulpitis.

Tocompare clinical and radiographic outcome of partial pulpotomy and  fullpulpotomy using biodentine in mature permanent molar with clinical symptomsindicative of irreversible pulpitis

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
50
Inclusion Criteria
  • •Mature permanent molar •Strong and prolonged reaction to cold, which can last for minutes.
  • •Spontaneous dull pain that can be more or less suppressed by pain medication clinical diagnosis of irreversible pulpitis with/without periapical rarefaction.
  • •No signs of pulpal necrosis including sinus tract or swelling.
Exclusion Criteria
  • •Non restorable teeth.
  • •Negative response to cold testing, the presence of sinus tract or swelling.
  • •Bleeding could not be controlled after pulpotomy in 6 minutes .
  • •Insufficient bleeding after pulp exposure, the pulp is judged necrotic or partially necrotic •Medically compromised patient.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Resolution of pain, sensitivity and periapical lesion3 Month, 6 month, 12 month
Secondary Outcome Measures
NameTimeMethod
Dentine bridge formation3 Month, 6 Month, 12 Month

Trial Locations

Locations (1)

BHU, Varanasi

🇮🇳

Varanasi, UTTAR PRADESH, India

BHU, Varanasi
🇮🇳Varanasi, UTTAR PRADESH, India
Jyoti yadav
Principal investigator
07376645880
drjyotiyadav2024@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.